Home/ Supplements/ Vitamin K/ Vitamin K2 + D3

Vitamin K2 + D3

product on market Capsule Divine Bounty Safety: 80/100
80/100

This product is generally safe

  • Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
  • 100% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin D3 and K2 are supported by strong evidence for promoting calcium absorption and bone health. These nutrients work synergistically to regulate calcium distribution in the body. However, the specific evidence coverage for this product's formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)

Label

Product Label

Label for Vitamin K2 + D3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

125 mcg (625% DV)
Exceeds UL by 1.2× (UL: 0.1 mg) 608 studies (A:16, B:251)
600 mcg (500% DV)
5.0× RDA — above typical dose 275 studies (A:9, B:175)

Other Ingredients

Vegetable Cellulose Vegetarian Capsule
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take one (1) capsule per day, preferably with a meal, or as recommended by a healthcare professional.

Warnings & Precautions

Caution: Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a healthcare professional before using this or any dietary supplement.

Caution: Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a healthcare professional before using this or any dietary supplement. Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Formulation Notes

Suitable for vegetarian, vegan, non-GMO, and gluten-free diets.

Suitable for vegetarian, vegan, non-GMO, and gluten-free diets.

Non GMO

3-in-1 Formula

Vitamin K2 as MK-7 and MK-4

No: Preservatives, stearates, artificial ingredients, silicone dioxide, or titanium dioxide.

Does not contain: Soy, gluten, milk, egg, shellfish, corn, wheat, and peanuts.

Additional Information

Store in a cool, dry place.

Made in USA with global ingredients GMP Good manufacturing practices consistent quality GMO free no binders fillers or preservatives

Get exclusive discounts at www.divinebounty.com

Metadata

Product Details

UPC / SKUX001ZJPASD
DSLD Entry Date2020-07-23
Product TypeVitamin
FormCapsule
DSLD ID229564
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.